Zura Bio Ltd. (ZURA)
1.405
+0.16
(+13.31%)
USD |
NASDAQ |
Nov 10, 16:00
1.39
-0.02
(-1.07%)
After-Hours: 20:00
Zura Bio Market Cap : 135.31M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 119.42M |
| November 06, 2026 | 393.89M |
| November 05, 2026 | 358.26M |
| November 04, 2026 | 387.15M |
| November 03, 2026 | 384.26M |
| November 02, 2026 | 379.45M |
| October 30, 2026 | 389.08M |
| October 29, 2026 | 370.78M |
| October 28, 2026 | 418.93M |
| October 27, 2026 | 411.23M |
| October 26, 2026 | 342.85M |
| October 23, 2026 | 323.59M |
| October 22, 2026 | 336.84M |
| October 21, 2026 | 394.09M |
| October 20, 2026 | 381.69M |
| October 19, 2026 | 363.56M |
| October 16, 2026 | 370.24M |
| October 15, 2026 | 408.41M |
| October 14, 2026 | 420.81M |
| October 13, 2026 | 403.64M |
| October 12, 2026 | 381.69M |
| October 09, 2026 | 381.69M |
| October 08, 2026 | 394.09M |
| October 07, 2026 | 397.91M |
| October 06, 2026 | 377.87M |
| Date | Value |
|---|---|
| October 05, 2026 | 375.01M |
| October 02, 2026 | 392.19M |
| October 01, 2026 | 395.05M |
| September 30, 2026 | 396.96M |
| September 29, 2026 | 381.69M |
| September 28, 2026 | 391.23M |
| September 25, 2026 | 385.51M |
| September 24, 2026 | 396.96M |
| September 23, 2026 | 413.18M |
| September 22, 2026 | 430.36M |
| September 21, 2026 | 429.40M |
| September 18, 2026 | 425.58M |
| September 17, 2026 | 436.08M |
| September 16, 2026 | 439.90M |
| September 15, 2026 | 470.43M |
| September 14, 2026 | 497.15M |
| September 11, 2026 | 497.15M |
| September 10, 2026 | 513.37M |
| September 09, 2026 | 544.86M |
| September 08, 2026 | 584.94M |
| September 04, 2026 | 594.48M |
| September 03, 2026 | 561.08M |
| September 02, 2026 | 541.05M |
| September 01, 2026 | 539.14M |
| August 31, 2026 | 528.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.3859M |
| Brainstorm Cell Therapeutics, Inc. | 10.59M |
| Summit Therapeutics, Inc. | 14.25B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 146.92M |
Market Cap Related Metrics
| PEG Ratio | -0.0147 |
| Price to Book Value | 0.7616 |
| Price | 1.405 |
| Earnings Yield | -88.84% |
| PEGY Ratio | -0.0147 |